Trust Company’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.6K | Hold |
221
| – | – | ﹤0.01% | 420 |
|
|
2026
Q1 | $12.2K | Sell |
221
-612
| -73% | -$33.2K | ﹤0.01% | 421 |
|
|
2025
Q4 | $40.9K | Buy |
+833
| New | +$38.9K | ﹤0.01% | 308 |
|
|
2025
Q2 | – | Sell |
-612
| Closed | -$23.7K | – | 432 |
|
|
2025
Q1 | $23.7K | Hold |
612
| – | – | ﹤0.01% | 276 |
|
|
2024
Q4 | $20.7K | Hold |
612
| – | – | ﹤0.01% | 280 |
|
|
2024
Q3 | $25K | Hold |
612
| – | – | ﹤0.01% | 248 |
|
|
2024
Q2 | $23.6K | Hold |
612
| – | – | ﹤0.01% | 239 |
|
|
2024
Q1 | $26.2K | Hold |
612
| – | – | ﹤0.01% | 226 |
|
|
2023
Q4 | $22.7K | Hold |
612
| – | – | ﹤0.01% | 230 |
|
|
2023
Q3 | $22.2K | Hold |
612
| – | – | ﹤0.01% | 231 |
|
|
2023
Q2 | $21.8K | Hold |
612
| – | – | ﹤0.01% | 231 |
|
|
2023
Q1 | $21.8K | Hold |
612
| – | – | ﹤0.01% | 228 |
|
|
2022
Q4 | $22K | Buy |
+612
| New | +$20.4K | ﹤0.01% | 220 |
|
|
2022
Q3 | – | Sell |
-612
| Closed | -$33K | – | 332 |
|
|
2022
Q2 | $33K | Hold |
612
| – | – | 0.01% | 213 |
|
|
2022
Q1 | $33K | Hold |
612
| – | – | 0.01% | 221 |
|
|
2021
Q4 | $34K | Hold |
612
| – | – | 0.01% | 202 |
|
|
2021
Q3 | $29K | Buy |
612
+96
| +19% | +$4.82K | 0.01% | 202 |
|
|
2021
Q2 | $26K | Buy |
+516
| New | +$24.8K | 0.02% | 202 |
|
|
2020
Q4 | – | Sell |
-217
| Closed | -$10K | – | 302 |
|
|
2020
Q3 | $10K | Hold |
217
| – | – | 0.01% | 257 |
|
|
2020
Q2 | $11K | Hold |
217
| – | – | 0.01% | 236 |
|
|
2020
Q1 | $10K | Hold |
217
| – | – | 0.01% | 224 |
|
|
2019
Q4 | $13K | Hold |
217
| – | – | 0.01% | 230 |
|
|
2019
Q3 | $12K | Hold |
217
| – | – | 0.01% | 242 |
|
|
2019
Q2 | $11K | Hold |
217
| – | – | 0.01% | 242 |
|
|
2019
Q1 | $11K | Hold |
217
| – | – | 0.01% | 273 |
|
|
2018
Q4 | $10K | Buy |
+217
| New | +$10.7K | 0.01% | 266 |
|
|
2017
Q4 | – | Sell |
-360
| Closed | -$18K | – | 377 |
|
|
2017
Q3 | $18K | Hold |
360
| – | – | 0.01% | 216 |
|
|
2017
Q2 | $19K | Hold |
360
| – | – | 0.01% | 222 |
|
|
2017
Q1 | $19K | Hold |
360
| – | – | 0.01% | 242 |
|
|
2016
Q4 | $17K | Sell |
360
-46
| -11% | -$2.27K | 0.01% | 251 |
|
|
2016
Q3 | $22K | Buy |
406
+46
| +13% | +$2.52K | 0.01% | 231 |
|
|
2016
Q2 | $20K | Hold |
360
| – | – | 0.01% | 227 |
|
|
2016
Q1 | $18K | Hold |
360
| – | – | 0.01% | 233 |
|
|
2015
Q4 | $18.2K | Sell |
360
-192
| -35% | -$9.79K | 0.01% | 237 |
|
|
2015
Q3 | $27K | Buy |
552
+192
| +53% | +$9.99K | 0.02% | 215 |
|
|
2015
Q2 | $19K | Hold |
360
| – | – | 0.01% | 250 |
|
|
2015
Q1 | $21K | Buy |
+360
| New | +$20.6K | 0.01% | 203 |
|
Other funds holding GSK
JEST
Trust Company's GSK Position: Q2 2026 in Review
Trust Company held its GSK (GSK) position steady in Q2 2026 at 221 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #420.
Trust Company first reported a position in GSK in Q1 2015 and has held it in 37 quarters since. The position peaked at $40.9K in Q4 2025. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.
- Trust Company held 221 shares of GSK worth $11.6K as of Q2 2026.
- Trust Company left its GSK share count unchanged in Q2 2026.
- GSK made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #420 holding.
- Trust Company first reported a position in GSK in Q1 2015 and has held it in 37 quarters since.
- Trust Company's GSK position peaked at $40.9K in Q4 2025.
- 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.
Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.